Statin therapy in patients with heart failure and preserved left ventricular function

Circulation Journal

Volumn 73, Issue 7, 2009, Pages 1359-

  Roik, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PLACEBO; ROSUVASTATIN;

CHRONIC KIDNEY FAILURE; CLINICAL STUDY; COMORBIDITY; DIABETES MELLITUS; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; LETTER; MORTALITY; PRESERVED LEFT VENTRICULAR EJECTION FRACTION; PREVALENCE; RISK REDUCTION;

C-REACTIVE PROTEIN; FLUOROBENZENES; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; PYRIMIDINES; STROKE VOLUME; SULFONAMIDES; VENTRICULAR FUNCTION, LEFT;

EID: 68149173375     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0242     Document Type: Letter

References (9)

1. Yamamoto K, Sakata Y, Ohtani T, Takeda Y, Mano T. Heart failure with preserved ejection fraction: What is known and unknown. Circ J 2009; 73: 404-410.
2. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259. (Pubitemid 44079340)
3. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269. (Pubitemid 44088349)
4. Cleland JGF, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J. The perindopril in elderly people with chronic heart failure. (PEP-CHF) study. Eur Heart J 2006; 27: 2338-2345. (Pubitemid 44453578)
5. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al, CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection function: The CHARM-PRESERVED Trial. Lancet 2003; 362: 777-781.
6. Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: The Ancillary Digitalis Investigation Group trial. Circulation 2006; 114: 397-403. (Pubitemid 44264821)
7. Kjekhus J, Apetrei E, Barrios V, Bohm M, Cleland JGF, Cornel JH, et al, for the CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007; 357: 2248-2261.
8. Fukuta H, Sane DC, Brucks S, Little W. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: A preliminary report. Circulation 2005; 112: 357-363. (Pubitemid 41022076)
9. Roik M, Starczewska MH, Huczek Z, Kochanowski J, Opolski G. Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function: A preliminary report. Acta Cardiol 2008; 6: 683-692.